Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 06, 2022 Filed Apr 7, 2022 16:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 4,020 | $299.13 | $1,202,498.58 |
DisclosureSEC source: 0001209191-22-023608 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,817,049 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $298.56 to $299.5513, inclusive. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 16:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 6,652 | $298.00 | $1,982,322.61 |
DisclosureSEC source: 0001209191-22-023608 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,821,069 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $297.56 to $298.50, inclusive. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 16:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 5,467 | $297.13 | $1,624,393.31 |
DisclosureSEC source: 0001209191-22-023608 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,827,721 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $296.56 to $297.5577, inclusive. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 16:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,473 | $296.04 | $732,097.03 |
DisclosureSEC source: 0001209191-22-023608 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,833,188 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.56 to $296.5578, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10) and (11) to this Form 4. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 18:35 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 6,534 | $295.34 | $1,929,764.63 |
DisclosureSEC source: 0001209191-22-023450 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,835,661 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.00 to $295.78, inclusive. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 18:35 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 38,039 | $294.49 | $11,202,219.23 |
DisclosureSEC source: 0001209191-22-023450 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,842,195 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $294.00 to $294.9961, inclusive. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 18:35 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 69,183 | $293.37 | $20,296,355.08 |
DisclosureSEC source: 0001209191-22-023450 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,880,234 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.00 to $293.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| April 04, 2022 Filed Apr 5, 2022 18:31 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 39,393 | $293.15 | $11,548,136.74 |
DisclosureSEC source: 0001209191-22-022913 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,949,417 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.00 to $293.58, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 18:34 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,000 | $293.02 | $293,019.00 |
DisclosureSEC source: 0001209191-22-022249 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,988,810 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.005 to $293.14, inclusive. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 18:34 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 164,376 | $292.38 | $48,059,761.75 |
DisclosureSEC source: 0001209191-22-022249 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,989,810 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.00 to $292.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 16:51 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,500 | $292.03 | $730,075.00 |
DisclosureSEC source: 0001209191-22-021707 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,154,186 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.00 to $292.19, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 20:37 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 100 | $293.00 | $29,300.00 |
DisclosureSEC source: 0001209191-22-021598 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,156,686 Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 20:37 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 4,241 | $292.37 | $1,239,953.89 |
DisclosureSEC source: 0001209191-22-021598 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,156,786 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.00 to $292.85 , inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 28, 2022 Filed Mar 29, 2022 18:14 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 7,538 | $292.16 | $2,202,264.39 |
DisclosureSEC source: 0001209191-22-021429 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,161,027 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.00 to $292.47, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 21, 2022 Filed Mar 22, 2022 20:52 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 34 | $289.64 | $9,847.76 |
DisclosureSEC source: 0000059478-22-000104 · wf-form4_164798234545441.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 798 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| March 21, 2022 Filed Mar 22, 2022 20:49 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 34 | $289.64 | $9,847.76 |
DisclosureSEC source: 0000059478-22-000102 · wf-form4_164798215545894.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,170 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| March 21, 2022 Filed Mar 22, 2022 20:54 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 39 | $289.64 | $11,295.96 |
DisclosureSEC source: 0000059478-22-000106 · wf-form4_164798246074827.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,416 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| March 21, 2022 Filed Mar 22, 2022 20:56 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 43 | $289.64 | $12,454.52 |
DisclosureSEC source: 0000059478-22-000108 · wf-form4_164798257682756.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,684 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| March 21, 2022 Filed Mar 22, 2022 20:58 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 33 | $289.64 | $9,558.12 |
DisclosureSEC source: 0000059478-22-000110 · wf-form4_164798270471935.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,170 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| March 21, 2022 Filed Mar 22, 2022 19:41 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 828 | $293.07 | $242,660.30 |
DisclosureSEC source: 0001209191-22-020505 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,168,565 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.02 to $293.11, inclusive. Read SEC document |
| March 21, 2022 Filed Mar 22, 2022 19:41 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 34,417 | $292.41 | $10,063,943.80 |
DisclosureSEC source: 0001209191-22-020505 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,169,393 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.00 to $292.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 18, 2022 Filed Mar 21, 2022 17:12 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 21,357 | $289.21 | $6,176,722.04 |
DisclosureSEC source: 0001209191-22-020199 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,203,810 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $289.00 to $289.65, inclusive. Read SEC document |
| March 18, 2022 Filed Mar 21, 2022 17:12 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 110,871 | $288.42 | $31,977,524.69 |
DisclosureSEC source: 0001209191-22-020199 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,225,167 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $288.00 to $288.99, inclusive. Read SEC document |
| March 18, 2022 Filed Mar 21, 2022 17:12 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 77,772 | $287.56 | $22,364,116.32 |
DisclosureSEC source: 0001209191-22-020199 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,336,038 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $287.00 to $287.9997, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| March 17, 2022 Filed Mar 17, 2022 20:12 UTC |
Jonsson PatrikSVP&Pres, LLY Imm, LLY USA&CCO
|
SaleCommon Stock | 673 | $277.20 | $186,555.60 |
DisclosureSEC source: 0000059478-22-000098 · wf-form4_164754794178841.xml · nonDerivative · entry 1 Jonsson Patrik · CIK 0001786054 · SVP&Pres, LLY Imm, LLY USA&CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,362 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2021. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 15:48 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 49,320 | $284.86 | $14,049,196.56 |
DisclosureSEC source: 0001209191-22-019973 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,413,810 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $284.50 to $285.32, inclusive. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 15:48 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 84,767 | $283.93 | $24,067,894.31 |
DisclosureSEC source: 0001209191-22-019973 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,463,130 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $283.50 to $284.49, inclusive. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 15:48 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 85,913 | $283.06 | $24,318,361.95 |
DisclosureSEC source: 0001209191-22-019973 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,547,897 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $282.50 to $283.495, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 15:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 16,402 | $276.16 | $4,529,625.53 |
DisclosureSEC source: 0001209191-22-019093 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,633,810 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.00 to $276.43, inclusive. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 15:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 110,782 | $275.49 | $30,518,779.27 |
DisclosureSEC source: 0001209191-22-019093 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,650,212 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.00 to $275.99, inclusive. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 15:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 72,816 | $274.44 | $19,983,623.04 |
DisclosureSEC source: 0001209191-22-019093 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,760,994 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.00 to $274.99, inclusive. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 15:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 18,539 | $273.05 | $5,062,092.49 |
DisclosureSEC source: 0001209191-22-019093 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,833,810 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.95 to $273.37, inclusive. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 15:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,030 | $272.43 | $280,602.90 |
DisclosureSEC source: 0001209191-22-019093 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,852,349 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.855 to $272.79, inclusive. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 15:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 506 | $271.04 | $137,146.24 |
DisclosureSEC source: 0001209191-22-019093 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,853,379 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.735 to $271.61, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5) and (6) to this Form 4. Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 18:13 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 29,023 | $270.25 | $7,843,407.70 |
DisclosureSEC source: 0001209191-22-018748 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,853,885 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.00 to $270.75 , inclusive. Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 18:13 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 144,062 | $269.21 | $38,783,507.27 |
DisclosureSEC source: 0001209191-22-018748 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,882,908 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.00 to $269.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 19:02 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 21,840 | $269.05 | $5,875,986.48 |
DisclosureSEC source: 0001209191-22-018419 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,026,970 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.00 to $269.41, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 17:04 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 28,187 | $267.30 | $7,534,441.47 |
DisclosureSEC source: 0001209191-22-018106 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,048,810 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.00 to $267.68, inclusive. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 17:04 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 156,795 | $266.29 | $41,753,097.35 |
DisclosureSEC source: 0001209191-22-018106 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,076,997 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.00 to $266.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 17:39 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,525 | $267.50 | $675,432.45 |
DisclosureSEC source: 0001209191-22-017793 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,233,792 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.23 to $267.67, inclusive. Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 17:39 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 17,493 | $266.38 | $4,659,715.37 |
DisclosureSEC source: 0001209191-22-017793 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,236,317 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.00 to $266.93, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 18:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 5,435 | $263.29 | $1,430,975.72 |
DisclosureSEC source: 0001209191-22-016578 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,253,810 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.21 to $263.42, inclusive. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 18:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 109,667 | $262.69 | $28,807,875.90 |
DisclosureSEC source: 0001209191-22-016578 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,259,245 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.21 to $263.20, inclusive. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 18:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 77,335 | $261.90 | $20,253,649.83 |
DisclosureSEC source: 0001209191-22-016578 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,368,912 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.21 to $262.205, inclusive. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 18:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 17,563 | $260.69 | $4,578,445.78 |
DisclosureSEC source: 0001209191-22-016578 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,446,247 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.21 to $261.205, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:30 UTC |
Jonsson PatrikSVP&Pres, LLY Imm, LLY USA&CCO
|
SaleCommon Stock | 675 | $247.56 | $167,103.00 |
DisclosureSEC source: 0000059478-22-000088 · wf-form4_164635021144333.xml · nonDerivative · entry 1 Jonsson Patrik · CIK 0001786054 · SVP&Pres, LLY Imm, LLY USA&CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,035 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2021. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:36 UTC |
Hakim AnatSVP, GC & Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,929 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-22-000090 · wf-form4_164635055799971.xml · derivative · entry 3 Hakim Anat · CIK 0001685556 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 · derivative.exercise_date: The restricted stock units vested on March 1, 2022. F2 · derivative.expiration_date: The restricted stock units vested on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:36 UTC |
Hakim AnatSVP, GC & Secretary
|
Tax withholdingCommon Stock | 3,500 | $249.95 | $874,825.00 |
DisclosureSEC source: 0000059478-22-000090 · wf-form4_164635055799971.xml · nonDerivative · entry 2 Hakim Anat · CIK 0001685556 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,864 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:36 UTC |
Hakim AnatSVP, GC & Secretary
|
Exercise / conversionCommon Stock | 7,929 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-22-000090 · wf-form4_164635055799971.xml · nonDerivative · entry 1 Hakim Anat · CIK 0001685556 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,364 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 7, 2022 22:06 UTC |
Runge Marschall SDirector
|
PurchaseCommon Stock | 202 | $246.78 | $49,849.56 |
DisclosureSEC source: 0000059478-22-000092 · wf-form4_164669076634205.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,436 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.